Decreased CETP activity is associated with angiographic coronary artery disease in humans: Associations with other lipid parameters and LDL particle size

被引：0
|
作者：
Goss, SPA [1 ]
Berger, PB [1 ]
Ballman, KV [1 ]
Scott, CG [1 ]
Lagerstedt, SA [1 ]
McConnell, JP [1 ]
机构：
[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA
来源：
CIRCULATION | 2001年 / 104卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1502
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [1] Decrease in CETP activity by fenofibrate may increase LDL particle size measured by HPLC method in patients with coronary artery disease
    Kiyanagi, T.
    Miyazaki, T.
    Kume, A.
    Ohmura, H.
    Shimada, K.
    Tanimoto, K.
    Miyauchi, K.
    Mokuno, H.
    Daida, H.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 559 - 559
  • [2] LDL Particle Number (LDL-P) Distribution in Patients with Angiographic Coronary Artery Disease on Lipid-Lowering Medication
    Malave, Hector A.
    Castro, Manuel
    Seigle, Nancy
    Winegar, Deborah A.
    Pourfarzib, Ray
    [J]. CIRCULATION, 2012, 126 (21)
  • [3] Lipoprotein(a) and LDL particle size are related to the severity of coronary artery disease
    Moon, Jae-Youn
    Kwon, Hyuck Moon
    Kwon, Sung Woo
    Yoon, Se-Jung
    Kim, Jung-Sun
    Lee, Sung-Ju
    Park, Jong Kwan
    Rhee, Ji-Hyuck
    Yoon, Young Won
    Hong, Bum-Kee
    Rim, Se-Joong
    Kim, Hyun Seung
    [J]. CARDIOLOGY, 2007, 108 (04) : 282 - 289
  • [4] Multilocus genetic determinants of LDL particle size in coronary artery disease families
    Rotter, JI
    Bu, XD
    Cantor, RM
    Warden, CH
    Brown, J
    Gray, RJ
    Blanche, PJ
    Krauss, RM
    Lusis, AJ
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1996, 58 (03) : 585 - 594
  • [5] Coronary artery disease, its associations with ocular, genetic and blood lipid parameters
    Indrė Matulevičiūtė
    Vacis Tatarūnas
    Vilius Skipskis
    Ieva Čiapienė
    Audronė Veikutienė
    Vaiva Lesauskaitė
    Olivija Dobilienė
    Dalia Žaliūnienė
    [J]. Eye, 2024, 38 : 372 - 379
  • [6] Coronary artery disease, its associations with ocular, genetic and blood lipid parameters
    Matuleviciute, Indre
    Tatarunas, Vacis
    Skipskis, Vilius
    Ciapiene, Ieva
    Veikutiene, Audrone
    Lesauskaite, Vaiva
    Dobiliene, Olivija
    Zaliuniene, Dalia
    [J]. EYE, 2023, 38 (2) : 372 - 379
  • [7] Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque
    Ooi, Esther M. M.
    Ellis, Katrina L.
    Barrett, P. Hugh R.
    Watts, Gerald F.
    Hung, Joseph
    Beilby, John P.
    Thompson, Peter L.
    Stobie, Paul
    McQuillan, Brendan M.
    [J]. ATHEROSCLEROSIS, 2018, 275 : 232 - 238
  • [8] MULTILOCUS GENETIC DETERMINATION OF LDL PARTICLE-SIZE IN CORONARY-ARTERY DISEASE FAMILIES
    ROTTER, JI
    BU, X
    CANTOR, R
    WARDEN, CH
    XIA, YR
    DEMEESTER, C
    TERYUA, S
    DANESHMAND, S
    BROWN, J
    GRAY, RJ
    BLANCHE, PJ
    KRAUSS, R
    LUSIS, AJ
    [J]. CLINICAL RESEARCH, 1994, 42 (01): : A16 - A16
  • [9] Lipoprotein-associated phospholipase A2 activity predicts cardiac and total mortality independently of angiographic coronary artery disease status, LDL-size, C-reactive protein, and other risk factors
    Winkler, K.
    Winkelmann, B. R.
    Marz, W.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 671 - 671
  • [10] Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk?
    Zeljkovic, Aleksandra
    Spasojevic-Kalimanovska, Vesna
    Vekic, Jelena
    Jelic-Ivanovic, Zorana
    Topic, Aleksandra
    Bogavac-Stanojevic, Natasa
    Spasic, Slavica
    Vujovic, Ana
    Kalimanovska-Ostric, Dimitra
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2008, 8 (02) : 109 - 116
12345